Treatment of severe psychosis due to ectopic Cushing’s syndrome

Abstract

Severe psychosis in patients with Cushing’s syndrome is rare and generally difficult to treat. We report a 46-yr-old woman suffering from Cushing’s syndrome caused by an inoperable ACTH-producing lung carcinoma. She was initially treated with chemotherapy and radiotherapy. Six months later she presented with severe psychosis. Laboratory findings revealed a severe hypokaliemia and metabolic alkalosis, which was caused by extremely high serum ACTH (788 ng/l) and cortisol (4.2 mumol/l). She was unresponsive to treatment with conventional antipsychotic drugs; she was therefore sedated and intubated. Treatment was started iv with etomidate, which blocks the cortisol synthesis, and orally by nasogastric tube with mifepristone, which competes with cortisol for binding to their receptors. To counteract adrenal insufficiency, she received corticosteroids. After 5 days there was a normalization of the ACTH, cortisol levels, and the metabolic disorders. After discontinuing etomidate she was extubated; there were no signs of psychosis observed. Computed tomography (CT) scan of the brain showed no metastasis, however CT scan of the abdomen showed liver metastasis and bilateral adrenal enlargement. Unfortunately, the clinical situation worsened and the patient died due to progression of the metastasis. This case report demonstrates the efficacy of a treatment of mifepristone with etomidate in a patient with an ectopic ACTH-producing Cushing’s syndrome.

This is a preview of subscription content, access via your institution.

REFERENCES

  1. 1.

    Dorn LD, Burgess Es, Friedman TC, Dubbert B, Gold PW, Chrousos GP. The longitudinal course of psychopathology in Cushing’s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 1997, 82: 912–9.

    PubMed  CAS  Google Scholar 

  2. 2.

    van der Lely AJ, Foeken K, van der Mast RC, Lamberts SW. Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486). Ann Internal Med 1991, 114: 143–4.

    Article  Google Scholar 

  3. 3.

    Nieman LK, Chrousos GP, Kellner C, et al. Succesful treatment of Cushing’s syndrome with glucocorticoid antagonist RU 486. J Clin Endocrinol Metab 1985, 61: 536–40.

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Belanoff JK, Flores BH, Kalezhan M, Sund B, Shatzberg AF. Rapid reversal of psychotic depression using mifepristone. J Clin Psychopaharmacol 2001, 21: 516–21.

    Article  CAS  Google Scholar 

  5. 5.

    Krakoff J, Koch CA, Calis KA, Alexander RH, Nieman LK. Use of parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing’s syndrome. J Clin Endocrinol Metab 2001, 86: 4104–8.

    PubMed  CAS  Google Scholar 

  6. 6.

    Drake WM, Perry LA, Hinds CJ, Lowe DG, Reznek RH, Besser GM. Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing’s syndrome and peritonitis. J Clin Endocrinol Metab 1998, 83: 3542–4.

    PubMed  CAS  Google Scholar 

  7. 7.

    Chu JW, Matthias DF, Belanoff J, Shatzberg A, Hoffman AR, Feldman D. Successful long-term treatment of refractory Cushing’s disease with high-dose mifepristone (RU 486). J Clin Endocrinol Metab 2001, 86: 3568–73.

    PubMed  CAS  Google Scholar 

  8. 8.

    Goldberg JR, Plescia MG, Anastasio GD. Mifepristone (RU 486) current knowledge and future prospects. Arch Fam Med 1998, 7: 219–22.

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Bertagna X, Bertagna C, Laudat MH, Husson JM, Girard F, Luton JP. Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing’s syndrome. J Clin Endocrinol Metab 1986, 63: 639–43.

    PubMed  Article  CAS  Google Scholar 

  10. 10.

    Schulte HM, Benker G, Reinwein D, Sippell WG, Allolio B. Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing’s syndrome and dose-response relationship in normal subjects. J Clin Endocrinol Metab 1990, 70: 1426–30.

    PubMed  Article  CAS  Google Scholar 

  11. 11.

    Gartner R, Albrecht M, Muller OA. Effect of etomidate on hypercortisolism due to ectopic ACTH production. Lancet 1986, 1: 275.

    PubMed  Article  CAS  Google Scholar 

  12. 12.

    Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab 2005, 90: 4955–62.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Y. M. Bilgin MD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bilgin, Y.M., van der Wiel, H.E., Fischer, H.R.A. et al. Treatment of severe psychosis due to ectopic Cushing’s syndrome. J Endocrinol Invest 30, 776–779 (2007). https://doi.org/10.1007/BF03350817

Download citation

Key-words

  • Cushing’s syndrome
  • hypercortisolism
  • psychotic disorders
  • etomidate
  • mifepristone